“Adjuvant topical dorzolamide or timolol with intravitreal bevacizumab for diabetic macular edema: A double-blind randomized controlled trial” (2024) Journal of Current Biomedical Reports, 5(1), pp. 14–19. doi:10.61882/jcbior.5.1.279.